Welgus Howard G. Insider Trading -- Recent SEC Form 4 Transactions

Welgus Howard G. (CIK 1801050) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy ARQT (1,019 shares), Buy ARQT (822 shares), Buy ARQT (2,255 shares), Sell ARQT (4,096 shares), Sell ARQT (635 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-17Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy1,019$7,653
2026-06-17Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy822$5,361
2026-06-17Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy2,255$19,461
2026-06-17Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell4,096$99,980
2026-06-17Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell635$16,300
2026-06-09Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy5,778$0
2026-04-03Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$238,801
2026-03-04Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$256,500
2026-02-04Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$250,500
2026-01-06Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$289,600
2025-12-03Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$302,100
2025-11-05Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$252,700
2025-10-03Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy9,538$16,024
2025-10-03Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell9,538$180,459
2025-10-03Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell462$8,741
2025-09-04Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$156,400
2025-09-04Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy10,000$0
2025-08-05Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy6,110$0
2025-08-05Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell6,110$87,373
2025-08-05Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy3,890$0
2025-08-05Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell3,890$55,627
2025-07-02Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell9,208$127,439
2025-06-20Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,139$135,558
2025-06-16Arcutis Biotherapeutics, Inc. (ARQT)DirectorBuy7,609$0
2025-05-05Arcutis Biotherapeutics, Inc. (ARQT)DirectorSell10,000$146,400

Source: SEC Form 4 filings · as of 2026-06-17